InvestorsHub Logo
Followers 1
Posts 261
Boards Moderated 0
Alias Born 09/11/2017

Re: guitar128 post# 9715

Monday, 10/05/2020 5:23:10 PM

Monday, October 05, 2020 5:23:10 PM

Post# of 9995
I'm confused Guitar. You've recently written InMed's leadership and maturation of IntegraSyn off yet now herald it as a formidable front runner. I personally have little confidence in InMed's execution on any program candidate. IMO a company like Willow exclusively focused on cannabinoid production, not one like InMed trying to balance priorities, offers a more targeted investment into cannabinoid production. They are also focused for now on CBG which is shaping up to be the next commercial blockbuster cannabinoid. One that will be marketed across various commercial products and sectors. Put a chunk into them after exiting a portion of InMed after the RS was announced and for now will keep adding. My hopes for InMed were mostly exhausted in '19 and it's only gotten worse for them and their shareholders.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News